The dual behavior of heat shock protein 70 and asymmetric dimethylarginine in relation to serum CRP levels in type 2 diabetes

Gene

Volumn 498, Issue 1, 2012, Pages 107-111

  Nakhjavani, Manouchehr ^a   Morteza, Afsaneh ^a   Asgarani, Firuzeh ^a   Khalilzadeh, Omid ^a   Ghazizadeh, Zaniar ^a   Bathaie, Seyede Zahra ^b   Esteghamati, Alireza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

C reactive protein; Heat shock proteins; HSP70; N,N dimethylarginine (asymmetric dimethylarginine); Type 2 diabetes mellitus

Indexed keywords

C REACTIVE PROTEIN; CREATININE; HEAT SHOCK PROTEIN 70; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; N(G),N(G) DIMETHYLARGININE; TRIACYLGLYCEROL;

ADULT; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

ADULT; ARGININE; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HSP70 HEAT-SHOCK PROTEINS; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; NITRIC OXIDE;

EID: 84858154010     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.01.085     Document Type: Article

References (41)

1. Antonova G., Lichtenbeld H., Xia T., Chatterjee A., Dimitropoulou C., Catravas J.D. Functional significance of hsp90 complexes with NOS and sGC in endothelial cells. Clin. Hemorheol. Microcirc. 2007, 37:19-35.
2. Benjamin I.J., McMillan D.R. Stress (heat shock) proteins: molecular chaperones in cardiovascular biology and disease. Circ. Res. 1998, 83:117-132.
3. Chan J.Y., Ou C.C., Wang L.L., Chan S.H. Heat shock protein 70 confers cardiovascular protection during endotoxemia via inhibition of nuclear factor-kappaB activation and inducible nitric oxide synthase expression in the rostral ventrolateral medulla. Circulation 2004, 110:3560-3566. Epub 2004 Nov 22.
4. Chan J.Y., et al. Heat shock protein 60 or 70 activates nitric-oxide synthase (NOS) I- and inhibits NOS II-associated signaling and depresses the mitochondrial apoptotic cascade during brain stem death. J. Biol. Chem. 2007, 282:4585-4600.
5. Chan J.Y., et al. Heat shock protein 60 or 70 activates nitric-oxide synthase (NOS) I- and inhibits NOS II-associated signaling and depresses the mitochondrial apoptotic cascade during brain stem death. J. Biol. Chem. 2007, 282:4585-4600. Epub 2006 Dec 5.
6. Crook M. Type 2 diabetes mellitus: a disease of the innate immune system? An update. Diabet. Med. 2004, 21:203-207.
7. Cullen P., Lorkowski S., Schulte H., Seedorf U., Assmann G. Inflammation in atherosclerosis, not yet time for a paradigm shift?. Curr. Opin. Lipidol. 2003, 14:325-328.
8. Dandona P., Aljada A., Chaudhuri A., Mohanty P., Garg R. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 2005, 111:1448-1454.
9. Duffy J.R., Salerno M. New blood test to measure heart attack risk: C-reactive protein. J. Cardiovasc. Nurs. 2004, 19:425-429.
10. Fiedler L. The DDAH/ADMA pathway is a critical regulator of NO signalling in vascular homeostasis. Cell Adh. Migr. 2008, 2:149-150.
11. Forstermann U., Sessa W.C. Nitric oxide synthases: regulation and function. Eur. Heart J. 2011.
12. Gullo C.A., Teoh G. Heat shock proteins: to present or not, that is the question. Immunol. Lett. 2004, 94:1-10.
13. Han T.S., Sattar N., Williams K., Gonzalez-Villalpando C., Lean M.E., Haffner S.M. Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes Care 2002, 25:2016-2021.
14. Hwang J., Lee H.I., Chang Y.S., Lee S.J., Kim K.P., Park S.I. 15-deoxy-Delta12,14-prostaglandin J2-induced down-regulation of endothelial nitric oxide synthase in association with HSP70 induction. Biochem. Biophys. Res. Commun. 2007, 357:206-211. Epub 2007 Mar 30.
15. Jacquier-Sarlin M.R., Fuller K., Dinh-Xuan A.T., Richard M.J., Polla B.S. Protective effects of hsp70 in inflammation. Experientia 1994, 50:1031-1038.
16. Kawashima S. The two faces of endothelial nitric oxide synthase in the pathophysiology of atherosclerosis. Endothelium 2004, 11:99-107.
17. Kim Y.J., et al. Prenatal increased asymmetric dimethylarginine is associated with placental heat-shock protein 70 and lectin-like oxidized low-density lipoprotein receptor-1 expression. Arch. Med. Res. 2007, 38:839-845. Epub 2007 Aug 20.
18. Kim Y.J., et al. Uterine artery notch is associated with increased placental endothelial nitric oxide synthase and heat shock protein. J. Matern. Fetal Neonatal Med. 2010, 23:153-157.
19. Li Z., Srivastava P. Heat-shock proteins. Curr. Protoc. Immunol. 2004, Appendix1, p. Appendix 1T.
20. Maas R., et al. Simultaneous assessment of endothelial function, nitric oxide synthase activity, nitric oxide-mediated signaling, and oxidative stress in individuals with and without hypercholesterolemia. Clin. Chem. 2008, 54:292-300. Epub 2007 Dec 10.
21. Malyshev I., Manukhina E.B., Mikoyan V.D., Kubrina L.N., Vanin A.F. Nitric oxide is involved in heat-induced HSP70 accumulation. FEBS Lett. 1995, 370:159-162.
22. Malyshev I., et al. Nitric oxide donor induces HSP70 accumulation in the heart and in cultured cells. FEBS Lett. 1996, 391:21-23.
23. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
24. Nakhjavani M., Karimi-Jafari H., Esteghamati A., Khalilzadeh O., Asgarani F., Ghadiri-Anari A. ADMA is a correlate of insulin resistance in early-stage diabetes independent of hs-CRP and body adiposity. Ann. Endocrinol. (Paris) 2010, 71:303-308.
25. Nakhjavani M., et al. Increased serum HSP70 levels are associated with the duration of diabetes. Cell Stress Chaperones 2010, 15:959-964. Epub 2010 May 23.
26. Nakhjavani M., et al. Serum heat shock protein 70 and oxidized LDL in patients with type 2 diabetes: does sex matter?. Cell Stress Chaperones 2011, 16:195-201.
27. Napoli C., de Nigris F., Williams-Ignarro S., Pignalosa O., Sica V., Ignarro L.J. Nitric oxide and atherosclerosis: an update. Nitric Oxide 2006, 15:265-279. Epub 2006 Apr 15.
28. Pacher P., Beckman J.S., Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 2007, 87:315-424.
29. Pedrycz A., Brzeski Z. l-arginine decreases heat shock protein 70 (marker of environmental stress) expression in kidney cells of rat fetuses during apoptosis-late effect of Adriamycin action. Ann. Agric. Environ. Med. 2006, 13:129-132.
30. Peng Z.Y., Zhao S.P., He B.M., Peng D.Q., Hu M. Protective effect of HDL on endothelial NO production: the role of DDAH/ADMA pathway. Mol. Cell. Biochem. 2011, 351:243-249.
31. Pepys M.B., Hirschfield G.M. C-reactive protein: a critical update. J. Clin. Invest. 2003, 111:1805-1812.
32. Pradhan A.D., Manson J.E., Rifai N., Buring J.E., Ridker P.M. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001, 286:327-334.
33. Ridker P.M., Wilson P.W., Grundy S.M. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?. Circulation 2004, 109:2818-2825.
34. Ritossa F. Discovery of the heat shock response. Cell Stress Chaperones 1996, 1:97-98.
35. Santoro M.G. Heat shock factors and the control of the stress response. Biochem. Pharmacol. 2000, 59:55-63.
36. Surdacki A. l-arginine analogs-inactive markers or active agents in atherogenesis?. Cardiovasc. Hematol. Agents Med. Chem. 2008, 6:302-311.
37. Tanigaki K., et al. C-reactive protein inhibits insulin activation of endothelial nitric oxide synthase via the immunoreceptor tyrosine-based inhibition motif of FcgammaRIIB and SHIP-1. Circ. Res. 2009, 104:1275-1282. Epub 2009 May 7.
38. Voegeli T.S., Wintink A.J., Chen Y., Currie R.W. Heat shock proteins 27 and 70 regulating angiotensin II-induced NF-kappaB: a possible connection to blood pressure control?. Appl. Physiol. Nutr. Metab. 2008, 33:1042-1049.
39. Wang J., Sim A.S., Wang X.L., Salonikas C., Naidoo D., Wilcken D.E. Relations between plasma asymmetric dimethylarginine (ADMA) and risk factors for coronary disease. Atherosclerosis 2006, 184:383-388. Epub 2005 Jun 6.
40. Yilmaz M.I., et al. Endothelial functions improve with decrease in asymmetric dimethylarginine (ADMA) levels after renal transplantation. Transplantation 2005, 80:1660-1666.
41. Yin C., Salloum F.N., Kukreja R.C. A novel role of microRNA in late preconditioning: upregulation of endothelial nitric oxide synthase and heat shock protein 70. Circ. Res. 2009, 104:572-575. Epub 2009 Feb 12.